小鼠适应(病毒），NR-1_Vaccinia virus

NR-51845??Enterovirus 71, Tainan/4643/1998, Mouse-Adapted(Viruses)|Enterovirus 71|Tainan/4643/1998, Mouse-Adapted| -60°C or colder |EB TarbetAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Enterovirus 71, Tainan/4643/1998, Mouse-Adapted, NR-51845.”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment. Enterovirus 71 (EV-71), Tainan/4643/1998, mouse-adapted was derived from EV-71, Tainan/4643/1998 which had undergone four serial passages in mice (BEI Resources NR-472). The virus was further adapted by six sequential passages in AG129 mice before purification. The complete genome of EV-71, Tainan/4643/1998 has been sequenced (GenBank: AF304458). EV-71, Tainan/4643/1998, mouse-adapted was adapted from BEI Resources NR-472 to improve replication in AG129 mice by six sequential passages in mice, and designated EV-71, Tainan/4643/1998, mouse-passage 10 (MP10). The mouse-adapted virus was plaque purified in rhabdomyosarcoma (RD) cells and a virus stock was prepared by replication in RD cells. Each vial contains approximately 1 mL of cell lysate and supernatant from rhabdomyosarcoma (RD) cells infected with EV-71, Tainan/4643/1998, mouse-adapted. Additional information and tools are available at ViPR (Virus Pathogen Resource).

NR-51844??Enterovirus D68, US/MO/14-18949, Mouse-Adapted(Viruses)|Enterovirus D68|US/MO/14-18949, Mouse-Adapted| -60°C or colder |EB TarbetAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Enterovirus D68, US/MO/14-18949, Mouse-Adapted, NR-51844.”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment. Enterovirus D68 (EV-D68), US/MO/14-18949, mouse-adapted was derived from EV-D68, US/MO/14-18949 by thirty sequential passages in AG129 mice before purification. The complete genome of EV-D68, US/MO/14-18949 has been sequenced (GenBank: MH708882).  EV-D68, US/MO/14-18949, mouse-adapted was derived from BEI Resources NR-49130 (EV-D68, US/MO/14-18949, which was isolated from a nasopharyngeal swab taken from a human in Missouri, USA, in August 2014) to improve replication in AG129 mice by thirty sequential passages in mice, and designated EV-D68, US/MO/14-18949, mouse passage 30 (MP30). The mouse-adapted virus was plaque purified in rhabdomyosarcoma (RD) cells and a virus stock was prepared by replication in RD cells. Each vial contains approximately 1 mL of cell lysate and supernatant from RD cells infected with EV-D68, US/MO/14-18949, mouse-adapted. Additional information and tools are available at ViPR (Virus Pathogen Resource).